Hikma Pharmaceutical reported $0.65 in EPS Earnings Per Share for its fiscal semester ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2024H1 Jun/2024 0.13 458.0000 Aug/08




Eps Change Date
Almirall EUR 0.07 0.03 Dec/2025
argenx SE USD 6.44 1.74 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Autolus Therapeutics Ltd USD -0.27 0.07 Mar/2026
Bayer EUR 0.95 1.76 Jun/2026
Fresenius EUR 0.82 0.04 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
GRIFOLS EUR 0.23 0.09 Jun/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Orion EUR 1 0.34 Jun/2026
Recordati EUR 0.65 0.08 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
UCB EUR 5.65 3.21 Dec/2025